Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Knowles Corp has successfully completed its portfolio transformation into a high-margin, focused industrial technology company following the divestiture of its Consumer MEMS Microphones business in late 2024. The company is experiencing strong secular tailwinds across its core end markets of Medtech, Defense, Industrial, and Electrification. With robust organic growth exceeding long-term targets, significant gross margin expansion, and the successful integration of Cornell Dubilier, Knowles is well-positioned to deliver sustained earnings growth and capital returns.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets4 analysts · as of 18 Aug 2026
Low · most bearish analyst$40.00
Mean target$43.75
High · most bullish analyst$48.00
Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$40.0020%

A broader macroeconomic slowdown impacts industrial and electrification markets, leading to inventory corrections at distributors. Slower-than-expected integration of Cornell Dubilier limits margin expansion.

Base CaseCentral scenario
$43.7550%
Matches the consensus mean

Knowles continues to execute on its post-transformation strategy, delivering organic revenue growth of 6-8% and maintaining strong adjusted EBITDA margins. The company successfully captures synergies from Cornell Dubilier and continues its disciplined share repurchase program.

Bull CaseUpside scenario
$48.0030%

Accelerating design wins in Medtech and sole-supplier defense programs drive organic revenue growth well above historical averages. Rapid margin expansion is achieved through high capacity utilization and favorable product mix, leading to significant EPS beats.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Successful transition to a high-margin industrial technology pure-play
  • Strong secular growth drivers in Medtech (hearing health) and Defense (electronic warfare)
  • Differentiated, custom-engineered product portfolio with high customer intimacy
  • Robust free cash flow generation supporting active share repurchases
Sign in / Sign up to read more
Key Investment Risks
  • Exposure to cyclicality in industrial and electrification end markets
  • Fluctuations in commodity pricing for raw materials such as palladium, gold, and copper
  • Integration risks associated with the Cornell Dubilier acquisition
Sign in / Sign up to read more
Thesis Invalidation Triggers
  1. Organic revenue growth falling consistently below the 4% floor
  2. Significant market share loss in key Medtech microphone or balanced armature platforms
  3. Material deterioration of adjusted EBITDA margins below 20%
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.